Literature DB >> 18981136

Role of human CD36 in bacterial recognition, phagocytosis, and pathogen-induced JNK-mediated signaling.

Irina N Baranova1, Roger Kurlander, Alexander V Bocharov, Tatyana G Vishnyakova, Zhigang Chen, Alan T Remaley, Gyorgy Csako, Amy P Patterson, Thomas L Eggerman.   

Abstract

Scavenger receptor CD36 mediates Staphylococcus aureus phagocytosis and initiates TLR2/6 signaling. We analyzed the role of CD36 in the uptake and TLR-independent signaling of various bacterium, including Escherichia coli, Klebsiella pneumoniae, Salmonella typhimurium, S. aureus, and Enterococcus faecalis. Expression of human CD36 in HeLa cells increased the uptake of both gram-positive and gram-negative bacteria compared with the control mock-transfected cells. Bacterial adhesion was associated with pathogen phagocytosis. Upon CD36 transfection, HEK293 cells, which demonstrate no TLR2/4 expression, acquired LPS responsiveness as assessed by IL-8 production. The cells demonstrated a marked 5- to 15-fold increase in cytokine release upon exposure to gram-negative bacteria, while the increase was much smaller (1.5- to 3-fold) with gram-positive bacteria and lipoteichoic acid. CD36 down-regulation utilizing CD36 small interfering RNA reduced cytokine release by 40-50% in human fibroblasts induced by both gram-negative and gram-positive bacteria as well as LPS. Of all MAPK signaling cascade inhibitors tested, only the inhibitor of JNK, a stress-activated protein kinase, potently blocked E. coli/LPS-stimulated cytokine production. NF-kappaB inhibitors were ineffective, indicating direct TLR-independent signaling. JNK activation was confirmed by Western blot analyses of phosphorylated JKN1/2 products. Synthetic amphipathic peptides with an alpha-helical motif were shown to be efficient inhibitors of E. coli- and LPS-induced IL-8 secretion as well as JNK1/2 activation/phosphorylation in CD36-overexpressing cells. These results indicate that CD36 functions as a phagocytic receptor for a variety of bacteria and mediates signaling induced by gram-negative bacteria and LPS via a JNK-mediated signaling pathway in a TLR2/4-independent manner.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18981136      PMCID: PMC3842223          DOI: 10.4049/jimmunol.181.10.7147

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  48 in total

1.  c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.

Authors:  B Jiménez; O V Volpert; F Reiher; L Chang; A Muñoz; M Karin; N Bouck
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

Review 2.  CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism.

Authors:  M Febbraio; D P Hajjar; R L Silverstein
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

3.  Intestinal sterol absorption mediated by scavenger receptors is competitively inhibited by amphipathic peptides and proteins.

Authors:  G Schulthess; S Compassi; M Werder; C H Han; M C Phillips; H Hauser
Journal:  Biochemistry       Date:  2000-10-17       Impact factor: 3.162

4.  Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells.

Authors:  Georg A Roth; Bernhard Moser; Franziska Roth-Walter; Mary Beth Giacona; Evis Harja; Panos N Papapanou; Ann Marie Schmidt; Evanthia Lalla
Journal:  Atherosclerosis       Date:  2006-04-18       Impact factor: 5.162

5.  Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.

Authors:  M Febbraio; E A Podrez; J D Smith; D P Hajjar; S L Hazen; H F Hoff; K Sharma; R L Silverstein
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

6.  Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway.

Authors:  L Arbibe; J P Mira; N Teusch; L Kline; M Guha; N Mackman; P J Godowski; R J Ulevitch; U G Knaus
Journal:  Nat Immunol       Date:  2000-12       Impact factor: 25.606

Review 7.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

8.  Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses.

Authors:  D H Wyllie; E Kiss-Toth; A Visintin; S C Smith; S Boussouf; D M Segal; G W Duff; S K Dower
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

Review 9.  Bacterial lipopolysaccharides and innate immunity.

Authors:  C Alexander; E T Rietschel
Journal:  J Endotoxin Res       Date:  2001

10.  The class A macrophage scavenger receptor is a major pattern recognition receptor for Neisseria meningitidis which is independent of lipopolysaccharide and not required for secretory responses.

Authors:  Leanne Peiser; Menno P J De Winther; Katherine Makepeace; Michael Hollinshead; Philip Coull; Joyce Plested; Tatsuhiko Kodama; E Richard Moxon; Siamon Gordon
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

View more
  67 in total

1.  OxLDL or TLR2-induced cytokine response is enhanced by oxLDL-independent novel domain on mouse CD36.

Authors:  Chenghui Xie; Hangpong Ng; Shanmugam Nagarajan
Journal:  Immunol Lett       Date:  2011-01-31       Impact factor: 3.685

Review 2.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

3.  Mettl3 Deficiency Sustains Long-Chain Fatty Acid Absorption through Suppressing Traf6-Dependent Inflammation Response.

Authors:  Xin Zong; Jing Zhao; Hong Wang; Zeqing Lu; Fengqin Wang; Huahua Du; Yizhen Wang
Journal:  J Immunol       Date:  2018-12-19       Impact factor: 5.422

4.  Allergen ligands in the initiation of allergic sensitization.

Authors:  Wayne R Thomas
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

5.  Key role of CD36 in Toll-like receptor 2 signaling in cerebral ischemia.

Authors:  Takato Abe; Munehisa Shimamura; Katherine Jackman; Hitomi Kurinami; Josef Anrather; Ping Zhou; Costantino Iadecola
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

6.  Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60.

Authors:  Irina N Baranova; Tatyana G Vishnyakova; Alexander V Bocharov; Asada Leelahavanichkul; Roger Kurlander; Zhigang Chen; Ana C P Souza; Peter S T Yuen; Robert A Star; Gyorgy Csako; Amy P Patterson; Thomas L Eggerman
Journal:  J Immunol       Date:  2011-12-28       Impact factor: 5.422

7.  Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells.

Authors:  Kye-Young Kim; Mark V Stevens; M Hasina Akter; Sarah E Rusk; Robert J Huang; Alexandra Cohen; Audrey Noguchi; Danielle Springer; Alexander V Bocharov; Tomas L Eggerman; Der-Fen Suen; Richard J Youle; Marcelo Amar; Alan T Remaley; Michael N Sack
Journal:  J Clin Invest       Date:  2011-08-25       Impact factor: 14.808

8.  CD36 deficiency attenuates experimental mycobacterial infection.

Authors:  Michael Hawkes; Xiaoming Li; Maryanne Crockett; Angelina Diassiti; Constance Finney; Gundula Min-Oo; W Conrad Liles; Jun Liu; Kevin C Kain
Journal:  BMC Infect Dis       Date:  2010-10-15       Impact factor: 3.090

9.  Gamma-Linolenic Acid Suppresses NF-κΒ Signaling via CD36 in the Lipopolysaccharide-Induced Inflammatory Response in Primary Goat Mammary Gland Epithelial Cells.

Authors:  Duoyao Cao; Jun Luo; WenJuan Zang; Dekun Chen; Huifen Xu; Huaiping Shi; Xiaoqi Jing
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

10.  CD36 and TLR interactions in inflammation and phagocytosis: implications for malaria.

Authors:  Laura K Erdman; Gabriela Cosio; Andrew J Helmers; D Channe Gowda; Sergio Grinstein; Kevin C Kain
Journal:  J Immunol       Date:  2009-10-28       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.